Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma

Tania Jain, Amylou C. Dueck, Heidi e. Kosiorek, Brenda F. Ginos, Angela Mayo, Craig B. Reeder, Marta Chesi, Joseph Mikhael, A. Keith Stewart, P. Leif Bergsagel, Rafael Fonseca

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)E504-E505
JournalAmerican journal of hematology
Volume91
Issue number12
DOIs
StatePublished - Dec 1 2016
Externally publishedYes

Fingerprint

Multiple Myeloma
130-nm albumin-bound paclitaxel

ASJC Scopus subject areas

  • Hematology

Cite this

Jain, T., Dueck, A. C., Kosiorek, H. E., Ginos, B. F., Mayo, A., Reeder, C. B., ... Fonseca, R. (2016). Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma. American journal of hematology, 91(12), E504-E505. https://doi.org/10.1002/ajh.24548

Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma. / Jain, Tania; Dueck, Amylou C.; Kosiorek, Heidi e.; Ginos, Brenda F.; Mayo, Angela; Reeder, Craig B.; Chesi, Marta; Mikhael, Joseph; Keith Stewart, A.; Leif Bergsagel, P.; Fonseca, Rafael.

In: American journal of hematology, Vol. 91, No. 12, 01.12.2016, p. E504-E505.

Research output: Contribution to journalLetter

Jain, T, Dueck, AC, Kosiorek, HE, Ginos, BF, Mayo, A, Reeder, CB, Chesi, M, Mikhael, J, Keith Stewart, A, Leif Bergsagel, P & Fonseca, R 2016, 'Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma', American journal of hematology, vol. 91, no. 12, pp. E504-E505. https://doi.org/10.1002/ajh.24548
Jain, Tania ; Dueck, Amylou C. ; Kosiorek, Heidi e. ; Ginos, Brenda F. ; Mayo, Angela ; Reeder, Craig B. ; Chesi, Marta ; Mikhael, Joseph ; Keith Stewart, A. ; Leif Bergsagel, P. ; Fonseca, Rafael. / Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma. In: American journal of hematology. 2016 ; Vol. 91, No. 12. pp. E504-E505.
@article{12f8bd4b8cd443b5855f22404b4a31f3,
title = "Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma",
author = "Tania Jain and Dueck, {Amylou C.} and Kosiorek, {Heidi e.} and Ginos, {Brenda F.} and Angela Mayo and Reeder, {Craig B.} and Marta Chesi and Joseph Mikhael and {Keith Stewart}, A. and {Leif Bergsagel}, P. and Rafael Fonseca",
year = "2016",
month = "12",
day = "1",
doi = "10.1002/ajh.24548",
language = "English (US)",
volume = "91",
pages = "E504--E505",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma

AU - Jain, Tania

AU - Dueck, Amylou C.

AU - Kosiorek, Heidi e.

AU - Ginos, Brenda F.

AU - Mayo, Angela

AU - Reeder, Craig B.

AU - Chesi, Marta

AU - Mikhael, Joseph

AU - Keith Stewart, A.

AU - Leif Bergsagel, P.

AU - Fonseca, Rafael

PY - 2016/12/1

Y1 - 2016/12/1

UR - http://www.scopus.com/inward/record.url?scp=84995579548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995579548&partnerID=8YFLogxK

U2 - 10.1002/ajh.24548

DO - 10.1002/ajh.24548

M3 - Letter

C2 - 27581088

AN - SCOPUS:84995579548

VL - 91

SP - E504-E505

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 12

ER -